These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 32983097)

  • 1. A Systematic, Unbiased Mapping of CD8
    Stryhn A; Kongsgaard M; Rasmussen M; Harndahl MN; Østerbye T; Bassi MR; Thybo S; Gabriel M; Hansen MB; Nielsen M; Christensen JP; Randrup Thomsen A; Buus S
    Front Immunol; 2020; 11():1836. PubMed ID: 32983097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.
    James EA; LaFond RE; Gates TJ; Mai DT; Malhotra U; Kwok WW
    J Virol; 2013 Dec; 87(23):12794-804. PubMed ID: 24049183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.
    Mateus J; Grifoni A; Voic H; Angelo MA; Phillips E; Mallal S; Sidney J; Sette A; Weiskopf D
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33198381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs.
    de Melo AB; Nascimento EJ; Braga-Neto U; Dhalia R; Silva AM; Oelke M; Schneck JP; Sidney J; Sette A; Montenegro SM; Marques ET
    PLoS Negl Trop Dis; 2013; 7(1):e1938. PubMed ID: 23383350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
    Adhikari UK; Rahman MM
    Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
    Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
    Front Immunol; 2021; 12():598778. PubMed ID: 33717077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
    Poluektov Y; George M; Daftarian P; Delcommenne MC
    Vaccine; 2021 Apr; 39(15):2110-2116. PubMed ID: 33744048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboptimal SARS-CoV-2-specific CD8
    Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
    Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
    Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization.
    Co MD; Kilpatrick ED; Rothman AL
    Immunology; 2009 Sep; 128(1 Suppl):e718-27. PubMed ID: 19740333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response.
    Blom K; Braun M; Ivarsson MA; Gonzalez VD; Falconer K; Moll M; Ljunggren HG; Michaëlsson J; Sandberg JK
    J Immunol; 2013 Mar; 190(5):2150-8. PubMed ID: 23338234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination.
    Koblischke M; Mackroth MS; Schwaiger J; Fae I; Fischer G; Stiasny K; Heinz FX; Aberle JH
    Sci Rep; 2017 Aug; 7(1):8907. PubMed ID: 28827760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
    Akondy RS; Monson ND; Miller JD; Edupuganti S; Teuwen D; Wu H; Quyyumi F; Garg S; Altman JD; Del Rio C; Keyserling HL; Ploss A; Rice CM; Orenstein WA; Mulligan MJ; Ahmed R
    J Immunol; 2009 Dec; 183(12):7919-30. PubMed ID: 19933869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model.
    Maciel M; Kellathur SN; Chikhlikar P; Dhalia R; Sidney J; Sette A; August TJ; Marques ET
    Virology; 2008 Aug; 378(1):105-17. PubMed ID: 18579176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.